These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27027032)

  • 1. IS THERE ANY DIFFERENCE IN THE PROGNOSIS FOR PATIENTS WITH PRIMARY OSTEOSARCOMA WITH A POOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY BETWEEN HUVOS GRADES I AND II?
    Bispo Júnior RZ; Camargo OP
    Rev Bras Ortop; 2011; 46(4):420-3. PubMed ID: 27027032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Location of residual viable tumor cells after neoadjuvant chemotherapy: A new concept with high prognostic performance in osteosarcoma.
    Kim SH; Shin KH; Moon SH; Kong Y; Suh JS; Yang WI
    J Surg Oncol; 2017 May; 115(6):752-759. PubMed ID: 28403564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
    Xu J; Xie L; Guo W
    Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinico-pathological Study of Limb Salvage Surgery for Osteosarcoma: Experience in a Rural Cancer Center.
    Vijayanarasimha D; Nayanar SK; Vikram S; Patil VM; Babu S; Satheesan B
    Indian J Surg Oncol; 2017 Jun; 8(2):136-141. PubMed ID: 28546707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of increases in tumor volume after neoadjuvant chemotherapy on the outcome of stage II osteosarcoma regardless of histological response.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jung ST; Jeon DG
    J Orthop Sci; 2009 May; 14(3):292-7. PubMed ID: 19499296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An expression signature classifies chemotherapy-resistant pediatric osteosarcoma.
    Mintz MB; Sowers R; Brown KM; Hilmer SC; Mazza B; Huvos AG; Meyers PA; Lafleur B; McDonough WS; Henry MM; Ramsey KE; Antonescu CR; Chen W; Healey JH; Daluski A; Berens ME; Macdonald TJ; Gorlick R; Stephan DA
    Cancer Res; 2005 Mar; 65(5):1748-54. PubMed ID: 15753370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution.
    Bacci G; Mercuri M; Longhi A; Ferrari S; Bertoni F; Versari M; Picci P
    Eur J Cancer; 2005 Sep; 41(14):2079-85. PubMed ID: 16115755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
    Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
    BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness and safety of polyethylene glycol liposome doxorubicin in the treatment of osteosarcoma].
    Yang YK; Xu HR; Huang Z; Li Y; Niu XH
    Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):692-696. PubMed ID: 32867464
    [No Abstract]   [Full Text] [Related]  

  • 10. Morphological aspects of the hepatic response to neoadjuvant therapy.
    Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
    Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osteosarcoma lung metastases. Survival after chemotherapy and surgery].
    Farfalli GL; Albergo JI; Lobos PA; Smith DE; Streitenberger PD; Pallotta Rodríguez MG; Aponte-Tinao LA
    Medicina (B Aires); 2015; 75(2):87-90. PubMed ID: 25919869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The prognostic factors in astrocytic tumors: analysis by the Kaplan-Meier method and the Weibull log-linear model].
    Hirano H; Asakura T; Yokoyama S; Kadota K; Kasamo S; Okahara K; Hirakawa W; Niiro M; Nakamura K; Nakayama M; Yamasaki I
    No Shinkei Geka; 1996 Sep; 24(9):809-15. PubMed ID: 8827730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteosarcoma of the spine: experience in 26 patients treated at the Massachusetts General Hospital.
    Schoenfeld AJ; Hornicek FJ; Pedlow FX; Kobayashi W; Garcia RT; DeLaney TF; Springfield D; Mankin HJ; Schwab JH
    Spine J; 2010 Aug; 10(8):708-14. PubMed ID: 20650409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telangiectatic osteosarcoma: a review of 87 cases.
    Angelini A; Mavrogenis AF; Trovarelli G; Ferrari S; Picci P; Ruggieri P
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2197-207. PubMed ID: 27469493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
    Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
    J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
    Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
    Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone microenvironment has an influence on the histological response of osteosarcoma to chemotherapy: retrospective analysis and preclinical modeling.
    Crenn V; Biteau K; Amiaud J; Dumars C; Guiho R; Vidal L; Nail LL; Heymann D; Moreau A; Gouin F; Redini F
    Am J Cancer Res; 2017; 7(11):2333-2349. PubMed ID: 29218254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine-potentiated chemotherapy for metastatic osteosarcoma.
    Kimura H; Tsuchiya H; Shirai T; Nishida H; Hayashi K; Takeuchi A; Ohnari I; Tomita K
    J Orthop Sci; 2009 Sep; 14(5):556-65. PubMed ID: 19802667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF expression as a prognostic marker in osteosarcoma.
    Bajpai J; Sharma M; Sreenivas V; Kumar R; Gamnagatti S; Khan SA; Rastogi S; Malhotra A; Bakhshi S
    Pediatr Blood Cancer; 2009 Dec; 53(6):1035-9. PubMed ID: 19621435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new relative tumor sizing method in epi-metaphyseal osteosarcoma.
    Kim SH; Shin KH; Park EH; Cho YJ; Park BK; Suh JS; Yang WI
    BMC Cancer; 2015 Apr; 15():284. PubMed ID: 25885468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.